Hermetica Superfood Encyclopedia
The Short Answer
Tinospora crispa contains at least 167 identified compounds—including the alkaloid columbamine (AChE IC₅₀ 48.1 μM), flavonoids, phenolic compounds (quantified at 384.909 mg GAE/g in stem extract), and immunomodulatory glycosides such as cordioside—that collectively act through antioxidant, anticholinesterase, and immunostimulatory pathways. The most substantiated preclinical benefit is immunomodulation, where ethanol and ethyl acetate stem extracts at 25–800 μg/mL significantly increased macrophage proliferation and upregulated INF-γ, IL-6, and IL-8 cytokine expression in RAW264.7 cell models; human clinical data confirming these effects remain absent.
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary KeywordTinospora crispa benefits
Tinospora crispa — botanical close-up
Health Benefits
**Immunomodulation**
Ethanol and ethyl acetate fractions of the stem increase RAW264.7 macrophage proliferation across a 25–800 μg/mL dose range and upregulate intracellular expression of IFN-γ, IL-6, and IL-8; the active compounds identified include cordioside, quercetin, paullinic acid, and boldine.
**Antioxidant Activity**
Ethanol stem extracts demonstrate strong free-radical scavenging capacity in DPPH and FRAP assays, with ethyl acetate fractions yielding the highest total phenolic content (up to 384.909 mg GAE/g); twenty metabolites—primarily flavonoids and alkaloids—show moderate-to-strong positive correlations (r ≥ 0.4) with antioxidant capacity.
**Acetylcholinesterase Inhibition**
The isolated alkaloid columbamine inhibits acetylcholinesterase with an IC₅₀ of 48.1 μM, a potency approaching that of the reference drug physostigmine (IC₅₀ 31.4 μM), suggesting potential relevance to cognitive and neurodegenerative pharmacology.
**Anticancer Potential**
Plant alkaloids modulate multidrug resistance-associated transport proteins to enhance chemosensitivity in resistant cancer cell lines, while phenolic compounds activate the Nrf2/ARE oxidative stress signaling pathway; all data are derived from in vitro models and require human validation.
**Antipyretic and Antidiabetic Use**
Traditional Malaysian and Thai medicine employs stem decoctions to manage fever and glycemic dysregulation; while ethnopharmacological surveys robustly document these uses, controlled mechanistic or clinical data specifically explaining these applications remain limited.
**Anti-inflammatory Effects**
Alkaloids and flavonoids present in stem extracts are reported to modulate inflammatory mediator release in cell-based models, complementing the immunomodulatory cytokine upregulation observed in macrophage assays; the specific pathways (e.g., NF-κB inhibition) warrant further mechanistic investigation.
**Neuroprotective Potential**
The AChE-inhibitory activity of columbamine and, to a lesser extent, dihydrodiscretamine (IC₅₀ 276.1 ± 1.8 μM) positions Tinospora crispa alkaloids as candidate scaffolds for neuroprotective drug discovery, though no animal or human neuroprotection trials have been published to date.
Origin & History
Natural habitat
Tinospora crispa is a climbing shrub native to tropical Southeast Asia, distributed across Malaysia, Thailand, Indonesia, the Philippines, and Sri Lanka, often found growing in secondary forests, forest edges, and along riverbanks at low to moderate elevations. The plant thrives in humid, tropical climates with well-drained soils and is typically found twining around host trees and shrubs. Stems are harvested from wild populations and traditional garden cultivation, dried, and used in folk medicine preparations throughout its native range.
“Tinospora crispa has been used for centuries in the traditional medicine systems of Malaysia, Thailand, Indonesia, and neighboring Southeast Asian countries, where it is known by regional names including 'patawali' in Malay and 'boraphet' in Thai. In Malaysian folk medicine, stem decoctions are a primary remedy for reducing fever, managing diabetes, and treating malaria and hypertension, reflecting a broad adaptogenic role attributed to the plant across different disease contexts. Thai traditional medicine similarly employs boraphet stem preparations for antipyretic and antidiabetic purposes, and the plant holds cultural significance as an accessible household remedy prepared from the dried, bitter-tasting stem bark. The bitter taste of the plant, attributable to its alkaloid and glycoside content, is considered pharmacologically meaningful in Ayurvedic-adjacent Southeast Asian traditions, where bitter herbs are systematically associated with hypoglycemic, hepatoprotective, and antipyretic properties.”Traditional Medicine
Scientific Research
The body of evidence for Tinospora crispa is primarily preclinical, comprising in vitro cell-culture studies and limited animal model work, with no peer-reviewed human clinical trials identified in the current literature. Phytochemical characterization studies have identified at least 167 compounds across 12 chemical classes, and metabolomic correlation analyses have linked specific metabolite classes to antioxidant capacity using DPPH and FRAP assays with quantified phenolic content reaching 384.909 mg GAE/g. Immunomodulatory activity has been demonstrated in RAW264.7 macrophage models at concentrations of 25–800 μg/mL, and AChE inhibition by isolated columbamine (IC₅₀ 48.1 μM) has been measured against a physostigmine standard; these are well-replicated in vitro findings but cannot be extrapolated to clinical efficacy without pharmacokinetic and human data. A major limitation acknowledged in the primary literature is that bioactive compound-to-activity attribution remains incomplete, as most pharmacological assessments used crude extracts, leaving the clinical translation of this herb in early-stage, hypothesis-generating territory.
Preparation & Dosage
Traditional preparation
**Traditional Decoction (Water Extract)**
Dried Tinospora crispa stems are boiled in water; this is the historically validated preparation method used in Malaysian and Thai folk medicine for fever and diabetes; no standardized volume or concentration has been established clinically.
**Ethanol Extract (Experimental)**
Ethanol (70–95%) extraction of dried stems yields the highest antioxidant activity in DPPH and FRAP assays and is the form most commonly used in preclinical research; no human dose has been established.
**Ethyl Acetate Fraction (Experimental)**
Yields the greatest total phenolic content and strongest immunomodulatory activity in cell models (active at 25–800 μg/mL in vitro); not currently available as a commercial supplement form.
**Standardized Extracts**
No commercial standardization to a specific marker compound (e.g., columbamine, borapetoside) has been established or validated by regulatory agencies; any commercial products claiming standardization should be evaluated critically.
**Dosage Note**
No safe or effective human dose has been determined from clinical trials; in vitro concentrations (25–1000 μg/mL) are laboratory reference ranges and do not translate directly to oral supplemental doses; use under ethnomedicinal guidance should be approached with caution given the absence of pharmacokinetic data.
Nutritional Profile
Tinospora crispa stems are not consumed as a nutritional food source and do not contribute meaningfully to macronutrient intake; the plant's relevance lies entirely in its secondary metabolite profile. The most quantitatively significant phytochemical class is phenolic compounds, measured at up to 384.909 mg GAE/g in stem extracts via UV-Vis spectrophotometry. Major alkaloid constituents include columbamine, magnoflorine, dihydrodiscretamine, and N-formylannonaine; flavonoids (including quercetin and flavone glycosides), glycosides (cordioside), triterpenes, diterpenes, phenylpropanoids, polyketides, and terpenoids are also present across the 167+ identified compounds. Bioavailability of individual compounds is unknown; phenolic content and antioxidant yield are significantly solvent-dependent, with ethanol outperforming water for antioxidant-active fractions and ethyl acetate yielding peak phenolic concentrations, suggesting that traditional water decoctions may not optimally extract all bioactive constituents.
How It Works
Mechanism of Action
The primary mechanistic pathways identified in preclinical research involve multi-target modulation by structurally diverse phytochemicals. Columbamine, an isoquinoline alkaloid, competitively inhibits acetylcholinesterase (IC₅₀ 48.1 μM), increasing synaptic acetylcholine availability through a mechanism similar to physostigmine. Phenolic compounds and flavonoids activate the Nrf2/ARE transcription factor pathway, upregulating endogenous antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase) to reduce oxidative stress burden in cells, while alkaloid fractions concomitantly inhibit multidrug resistance-related efflux transporters (e.g., P-glycoprotein), restoring intracellular drug accumulation in chemoresistant tumor cells. On the immunological axis, the ethyl acetate fraction compounds—cordioside (a glycoside), quercetin (a flavonoid), paullinic acid (a fatty acid derivative), and boldine (an aporphine alkaloid)—stimulate macrophage proliferation and augment intracellular cytokine synthesis (IFN-γ, IL-6, IL-8), likely through pattern recognition receptor sensitization and downstream MAPK/NF-κB signaling, though precise receptor-level binding data are not yet fully characterized.
Clinical Evidence
No registered or published human clinical trials evaluating Tinospora crispa for any health outcome were identified in the available scientific literature as of the knowledge cutoff. Ethnopharmacological evidence from Malaysia and Thailand strongly supports traditional use for fever management and glycemic control, but no controlled interventional studies in human subjects with defined endpoints, sample sizes, or effect size measurements have been conducted. In vitro and ex vivo macrophage models provide the strongest mechanistic data supporting immunostimulatory activity, while alkaloid-based AChE inhibition data from isolated compound studies represent a promising but unvalidated preclinical lead. Confidence in therapeutic efficacy for any specific clinical indication must therefore be rated as low, pending well-designed phase I/II human trials.
Safety & Interactions
Formal human safety data for Tinospora crispa are absent from the published literature, representing a critical evidence gap; no adverse event profiles, maximum tolerated doses, or long-term safety assessments in human subjects have been reported. Given the presence of pharmacologically active alkaloids—including AChE inhibitors such as columbamine—potential drug interactions with cholinergic agents (e.g., donepezil, rivastigmine), anticholinergic drugs, and antidiabetic medications (due to traditional hypoglycemic use) are mechanistically plausible but uncharacterized. Pregnant and lactating individuals should avoid use entirely given the complete absence of reproductive safety data and the biological activity of its alkaloid and glycoside constituents. The plant's intensely bitter alkaloid content and structural similarities to related Tinospora species warrant caution regarding hepatotoxic potential, a risk class observed with some members of the Menispermaceae family; until rigorous toxicological studies and human pharmacovigilance data are available, use should be limited to the context of traditional preparations under informed guidance.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Makabuhay (Philippines)Tinospora crispa (Tinospora crispa)Menispermum crispum L.Tinospora crispa (L.) Miers ex Hook.f. & ThomsonAkar patawaliPatawaliBoraphet
Frequently Asked Questions
What is Tinospora crispa used for traditionally?
In Malaysian and Thai traditional medicine, Tinospora crispa stem decoctions are primarily used to reduce fever, manage blood sugar levels in diabetes, and treat malaria and hypertension. The dried stems are boiled in water to produce a bitter decoction, and the plant's broad therapeutic reputation across Southeast Asia reflects its rich alkaloid and glycoside content. No human clinical trials have yet confirmed these traditional uses under controlled conditions.
What are the key active compounds in Tinospora crispa?
Tinospora crispa contains at least 167 identified compounds, with the most pharmacologically characterized being the alkaloids columbamine, magnoflorine, dihydrodiscretamine, and N-formylannonaine, alongside the immunomodulatory compounds cordioside, quercetin, paullinic acid, and boldine. Total phenolic content in stem extracts has been quantified at up to 384.909 mg GAE/g, reflecting a high density of antioxidant-active molecules. The alkaloid columbamine is among the most studied, demonstrating acetylcholinesterase inhibition with an IC₅₀ of 48.1 μM in vitro.
Does Tinospora crispa have evidence for treating diabetes?
Tinospora crispa is widely used in Malaysian and Thai folk medicine for diabetes management, and its antidiabetic reputation is well-documented ethnopharmacologically, but no published human clinical trials with glycemic outcome data have been identified. Animal model and in vitro studies suggest antioxidant and anti-inflammatory mechanisms that may be relevant to metabolic disease, but direct antidiabetic mechanisms in humans are uncharacterized. Individuals using this herb alongside prescribed antidiabetic medications should exercise caution due to potential additive hypoglycemic effects, though no formal interaction data exist.
Is Tinospora crispa safe to take as a supplement?
Formal human safety data for Tinospora crispa are currently absent from the peer-reviewed literature, making it impossible to define a safe supplemental dose or adverse event profile. The plant contains pharmacologically active alkaloids that are mechanistically capable of interacting with cholinergic drugs, antidiabetic agents, and potentially hepatically metabolized medications. Until controlled toxicological and human pharmacokinetic studies are published, supplemental use should be approached with caution, particularly by pregnant or lactating individuals and those on prescription medications.
How does Tinospora crispa compare to Tinospora cordifolia (guduchi)?
Tinospora crispa and Tinospora cordifolia (guduchi) are closely related members of the Menispermaceae family and share overlapping phytochemical profiles including alkaloids, glycosides, and flavonoids, but they differ in their geographic focus—crispa is the dominant medicinal species in Southeast Asia while cordifolia is central to Ayurvedic medicine in South Asia. Tinospora cordifolia has a larger published clinical research base, including some human trials for immunomodulation and diabetes, whereas Tinospora crispa research remains predominantly in vitro. The two species should not be considered interchangeable in dosing or safety assumptions until comparative pharmacokinetic studies are completed.
What extract form of Tinospora crispa shows the strongest immunomodulatory effects?
Ethanol and ethyl acetate stem extracts demonstrate the most potent immunomodulatory activity, with studies showing they increase macrophage proliferation and upregulate key immune cytokines like IFN-γ, IL-6, and IL-8 across therapeutic dose ranges. The ethanol extract appears particularly effective at activating immune cell responses through compounds like cordioside and quercetin. Water extracts are commonly used in traditional medicine but may have lower bioavailability of these active immunomodulatory compounds compared to solvent-based extracts.
Which populations may benefit most from Tinospora crispa supplementation based on current research?
Individuals seeking immune support and those with oxidative stress-related conditions may benefit most, given the herb's documented immunomodulatory and antioxidant properties. People with blood sugar management concerns represent another potential user group, though more human clinical trials are needed to establish optimal dosing. Those interested in traditional Southeast Asian remedies for general wellness and vitality may also find value, though individual health status and medication interactions should be assessed first.
How does the antioxidant potency of Tinospora crispa compare to its immunomodulatory effects in research?
While Tinospora crispa demonstrates strong free-radical scavenging capacity through its ethanol stem extracts, the immunomodulatory effects—particularly macrophage activation and cytokine upregulation—appear to be the more extensively studied and mechanistically characterized actions. Both activities likely contribute synergistically to the herb's traditional uses, though most mechanistic research has focused on the immune-enhancing properties mediated by compounds like cordioside and paullinic acid. The antioxidant component supports cellular protection but is often secondary in research emphasis compared to immune modulation.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w tinospora-crispa-tinospora-crispa-l-miers-ex-hookf-thomson curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
